key: cord-0983338-c13jdb6d
authors: Bulterys, Philip L.; Solis, Daniel; Verghese, Michelle; Huang, Chunhong; Sibai, Mamdouh; Costales, Cristina; Sahoo, Malaya K.; Pinsky, Benjamin A.
title: Diagnosis of Dengue in a returning traveler from Pakistan suspected of COVID-19, California, USA
date: 2021-08-06
journal: Diagn Microbiol Infect Dis
DOI: 10.1016/j.diagmicrobio.2021.115517
sha: b290268f8c9a7bcabc9c4578985860de2c7ee98f
doc_id: 983338
cord_uid: c13jdb6d

Dengue and COVID-19 co-circulation presents a diagnostic conundrum for physicians evaluating patients with acute febrile illnesses, both in endemic regions and among returning travelers. We present a case of a returning traveler from Pakistan who, following repeated negative SARS-CoV-2 tests, was found to have a Dengue virus serotype 2 infection.

Aedes aegypti or Aedes albopictus mosquito (1) . Over 390 million estimated human DENV infections occur annually (2) . Infections are endemic throughout tropical and subtropical areas, with incidence highest in South and Southeast Asia, Central and South America, and sub-Saharan Africa (3) . Infection with one of the four DENV serotypes can result in an acute febrile illness typically lasting 5-7 days and often accompanied by headache, retro-orbital pain, muscle and bone pain, and maculopapular rash (4) . A subset of cases will progress to severe dengue, a life-threatening illness characterized by systemic vascular leakage, marked thrombocytopenia, bleeding, shock, and organ dysfunction (3).

Distinguishing dengue from other febrile illnesses can be difficult due to overlapping clinical manifestations, and this has become especially problematic in the setting of the global coronavirus disease 2019 (COVID-19) pandemic. Infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can result in fever, myalgias, and other non-specific symptoms which may mimic dengue or malaria, presenting a diagnostic conundrum for physicians in endemic areas (5, 6) . In addition, co-circulation of DENV and SARS-CoV-2 raises the possibility of co-infection and enhanced severity of each illness (7, 8) . Some data suggest that social distancing measures aimed at mitigating the spread of COVID-19 have actually increased the spread of DENV, as most infections occur in the residential setting (9).

Co-circulation of DENV and SARS-CoV-2 also presents a diagnostic conundrum for physicians evaluating patients with acute febrile illnesses returning from travel to dengue endemic areas. In the United States in 2020, 332 dengue cases were reported to the Centers for Disease Control and Prevention, 252 (74%) of which were travel associated and 80 (26%) of which were locallytransmitted cases (10). All locally-transmitted cases occurred in the states of Florida (n = 70) and Texas (n = 10) (11). Appropriate diagnostic tools are vital to making the right diagnosis in these cases. In the case of dengue, diagnosis typically relies on serologic demonstration of IgM antibodies in an acute phase serum sample, IgG serologic testing using paired acute and convalescent phase plasma, or molecular assays such as real-time reverse transcription polymerase chain reaction (RT-PCR) (12). Accurate SARS-CoV-2 diagnosis relies on viral RNA detection by RT-PCR or other nucleic acid amplification tests (NAATs) (13) .

In October 2020, a 30 year old previously healthy woman presented to a Stanford telemedicine clinic appointment complaining of five days of fever (up to 102.6°F), fatigue, myalgias, ageusia, dysgeusia, itchy throat, frequent loose stools, abdominal cramping associated with meals, and anorexia. She did not have a rash, cough, or urinary symptoms. The day prior, she had also started having nausea and vomiting. The patient returned from a week-long trip to Pakistan six days prior (one day prior to the onset of her symptoms). The day prior to her clinic appointment, she presented to an outside emergency department and tested negative on SARS-CoV-2 NAAT, rapid influenza antigen test, mononucleosis heterophile screen, and urinalysis. Given that she was feeling generally unwell and complaining of symptoms suspicious for COVID-19, she was advised to present to the emergency department for repeat SARS-CoV-2 testing.

The patient presented to the Stanford emergency department later that day. Her temperature was 100.5°F on acetaminophen and ibuprofen. She disclosed that her mother, whom she had visited and co-habitated with in Pakistan, had developed similar symptoms recently and tested negative for SARS-CoV-2, and positive for DENV (testing method and serotype unknown). A physical exam revealed no rash, and a negative tourniquet test. Laboratory findings were significant for a leukopenia (2.5 K/µL), absolute neutropenia (1.58 K/µL), lymphocytopenia (0.75 K/µL), monocytopenia (0.16 K/µL), undetectable eosinophils (0.00 K/µL), elevated AST (54 U/L), and negative for SARS-CoV-2 by an Emergency Use Authorized RT-PCR targeting the envelope gene (13) . A chest X-ray showed no significant abnormalities. The patient was discharged home. Dengue virus RT-PCR targeting the 5' untranslated region and capsid gene of the DENV genome (14) was performed based on the patient's family history and returned positive, with a cycle threshold value of 19.3 (positive control = 27). The patient was notified by telephone of her positive DENV test result and instructed to rest, hydrate, and take antipyretics.

Serotype-specific, multiplex DENV RT-PCR (15) revealed that the etiologic virus in this case was Dengue virus serotype 2, the predominant serotype in Pakistan (16) . Serotype specific primers D2_750F2(ATGGATGTCATCAGAAGGGGCCTG) and D2_2300R2

(ACAGACAGTGAGGTGCTACGTGAATT) were used to generate an amplicon spanning the glycoprotein M and part of the envelope gene and sequenced by Sanger at Elim Biopharmaceuticals (Hayward, CA). The sequence was submitted to GenBank as MW463888.

The matching region from selected GenBank sequences were aligned using ClustalX2 (clustal.org) and a neighbor-joining tree was generated. MEGA5.2 (megasoftware.net) was used to create the phylogenetic tree. This revealed that the etiologic virus in this case clusters with other serotype 2 viruses of the cosmopolitan genotype ( Figure 1 ). This case illustrates the importance of clinical awareness of Dengue fever in returning travelers presenting with acute febrile illness during the COVID-19 pandemic. This is increasingly important given concerns that the COVID-19 pandemic may be amplifying the spread of dengue in endemic areas due to social distancing measures that increase residential exposure (9) , and disruptions to surveillance as a result of reallocation of limited resources (17, 18) . Additional studies will be required to fully understand the impact of the COVID-19 pandemic on spread and diagnosis of Dengue fever and other arboviral diseases, both in endemic areas such as Pakistan and among returning travelers.

PLB and BAP designed research. PLB, DS, MV, CH, MS, CC, MKS, and BAP performed research. PLB, DS, MKS, and BAP analyzed data. PLB, DS, MKS, and BAP wrote the paper.

None.

The authors declare no conflicts of interest.

The global distribution and burden of dengue

Dengue infection. Nat Rev Dis Primers

Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus

Tertiary Hospital in Singapore with Management of a Dual Outbreak of COVID-19 and Dengue

Emergence of co-infection of COVID-19 and dengue: A serious public health threat

Simultaneous dengue and COVID-19 epidemics: Difficult days ahead? PLoS Negl Trop Dis

Cocirculation of COVID-19 and dengue: A perspective from Pakistan

Impact of sars-cov-2 interventions on dengue transmission

Dengue: Guidelines for diagnosis, treatment, prevention and control

Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2

Single-Reaction Multiplex Reverse Transcription PCR for Detection of Zika, Chikungunya, and Dengue Viruses

Singlereaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses

Increasing airline travel may facilitate co-circulation of multiple dengue virus serotypes in Asia

Cocirculation of COVID-19 and dengue: A perspective from Pakistan

Dengue and COVID-19: A double burden to Brazil